Brief: Tenax Therapeutics Got Nasdaq Notice Granting Request For Extension Through March 25, 2024 To Evidence Compliance Minimum Bid Price Requirement
29/09/2023 21:42
Sept 29 (Reuters) - Tenax Therapeutics Inc TENX.O :
* TENAX THERAPEUTICS: GOT NASDAQ NOTICE GRANTING REQUEST FOR
EXTENSION THROUGH MARCH 25, 2024 TO EVIDENCE COMPLIANCE MINIMUM
BID PRICE REQUIREMENT
Further company coverage: TENX.O
((Reuters.Briefs@thomsonreuters.com;))